Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07126938 · ClinicalTrials.gov registry record
Alcohol Impairment Detection in Healthy Adult Users With the Gaize Device
A clinical trial, sponsored by Gaize.
- Completed
- Registry status
- 80
- Enrollment target
NCT07126938 is a clinical trial that has completed, run by Gaize. The registered enrollment target is 80 participants.
The verdict
NCT07126938 has completed, sponsored by Gaize.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
This study evaluates the effectiveness of the Gaize virtual reality headset as a non-invasive tool for detecting alcohol-related impairment through ophthalmic and neurological indicators. A total of 80 participants, evenly divided into an experimental (alcohol-consuming) and control (non-alcohol consuming) group, underwent baseline and post-consumption ocular assessments using the device. These assessments included: Lack of Smooth Pursuit, Horizontal Gaze Nystagmus at Maximum Deviation, Horizontal Gaze Nystagmus with Onset Prior to 45-Degrees, Vertical Gaze Nystagmus, Lack of Convergence, and Pupillary Rebound Dilation. The Gaize headset measured gaze vector and pupil size at 90 hertz per eye.
Interventions
- DRUG Alcoholic beverage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2024-03-21 |
| Est. Completion | 2024-11-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07126938
The ClinicalTrials.gov registry entry for NCT07126938 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gaize, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Alcoholic beverage is the first listed.
NCT07126938 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07126938 about?
NCT07126938 is a clinical study titled "Alcohol Impairment Detection in Healthy Adult Users With the Gaize Device". This study evaluates the effectiveness of the Gaize virtual reality headset as a non-invasive tool for detecting alcohol-related impairment through ophthalmic and neurological indicators. A total of 80 participants, evenly divided into an experimental (alcohol-consuming) and control (non-alcohol con...
What is the current status of trial NCT07126938?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2024-03-21. Estimated completion is 2024-11-22.
What interventions are being tested in trial NCT07126938?
The interventions under investigation include: Alcoholic beverage (DRUG).
Who is sponsoring clinical trial NCT07126938?
This trial is sponsored by Gaize, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.